When do the symptoms of autonomic nervous system malfunction appear in patients with Parkinson's disease?;Kada se pojavljuju simptomi oštećenja autonomnog nervnog sistema kod obolelih od Parkinsonove bolesti?

Vojnosanitetski Pregled

Volumn 71, Issue 4, 2014, Pages 346-351

  De Luka, Silvio R ^a   Svetel, Marina ^b   Pekmezović, Tatjana ^c   Milovanović, Branislav ^d   Kostić, Vladimir S ^b  

^a Institute of Pathology   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c Institute of Epidemiology   (Serbia)

^d UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Autonomic nervous system; Parkinson disease

Indexed keywords

LEVODOPA;

ACTIVITIES OF DAILY LIVING SCALE; ADRENERGIC SYSTEM; ADULT; ANXIETY; ARTICLE; AUTONOMIC NEUROPATHY; BLOOD PRESSURE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HAND GRIP; HEART RATE; HOEHN AND YAHR SCALE; HUMAN; HYPERPNEA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; RATING SCALE; SCHWAB ENGLAND SCALE; STANDING; SYMPTOM ASSESSMENT; UNIFIED PARKINSON DISEASE RATING SCALE; VALSALVA MANEUVER;

ACTIVITIES OF DAILY LIVING; AGED; ANTIPARKINSON AGENTS; ANXIETY; AUTONOMIC NERVOUS SYSTEM; CASE-CONTROL STUDIES; DEPRESSION; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; SERBIA; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84897939552     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1404346D     Document Type: Article

References (34)

1. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinsonism-a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55(3): 181-4.
2. Wenning GK, Ben-Shlomo Y, Hughes A, Daniel SE, Lees A, Quinn NP. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry 2000; 68(4): 434-40.
3. Allcock LM, Ullyart K, Kenny RA, Burn DJ. Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75(10):1470-1.
4. Kummer A, Teixeira AL. Neuropsychiatry of Parkinson's disease. Arq Neuropsiquiatr 2009; 67(3B): 930-9.
5. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008; 23(6): 837-44.
6. Gaenslen A, Swid I, Liepelt-Scarfone I, Godau J, Berg D. Cardiac sympathetic denervation preceding motor signs in Parkinson disease. Clin Auton Res 2007; 17(2): 118-21.
7. Gaenslen A, Swid I, Liepelt-Scarfone I, Godau J, Berg D. The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's disease. Mov Disord 2011; 26(4): 653-8.
8. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24(2): 197-211.
9. Ewing DJ. Recent advances in the non-invasive investigation of diabetic autonomic neuropathy. In: Bannister R, editor. Autonomic failure-a textbook of clinical disorders of autonomic nervous system. 2nd ed. Oxford: Oxford University Press; 1988.
10. Folstein MF, Folstein SE, McHugh PR. "Mini Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12(3): 189-98.
11. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
12. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32(1): 50-5.
13. Zakrzewska-Pniewska B, Jamrozik Z. Are electrophysiological autonomic tests useful in the assessment of dysautonomia in Parkinson's disease? Parkinsonism Relat Disord 2003; 9(3): 179-83.
14. Fischer M, Gemende I, Marsch WC, Fischer PA. Skin function and skin disorders in Parkinson's disease. J Neural Transm 2001; 108(2): 205-13.
15. Dewey RB Jr. Autonomic dysfunction in Parkinson's disease. Neurol Clin. 2004; 22(3 Suppl): S127-39.
16. Shibata M, Morita Y, Shimizu T, Takahashi K, Suzuki N. Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson's disease. J Neurol Sci 2009; 276(1-2): 79-83.
17. Buob A, Winter H, Kindermann M, Becker G, Möller JC, Oertel WH, et al. Parasympathetic but not sympathetic cardiac dysfunction at early stages of Parkinson's disease. Clin Res Cardiol 2010; 99(11): 701-6.
18. Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, et al. Axonal ά-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 2008; 131(Pt 3): 642-50.
19. Okada Y, Ito Y, Aida J, Yasuhara M, Ohkawa S, Hirokawa K. Lewy bodies in the sinoatrial nodal ganglion: clinicopathological studies. Pathol Int 2004; 54(Pt 3): 682-7.
20. Barbic F, Perego F, Canesi M, Gianni M, Biagiotti S, Costatino G, et al. Early abnormalities of vascular and cardiac autonomic control in Parkinson's disease without orthostatic hypotension. Hypertension 2007; 49(1): 120-126.
21. Mihci E, Kardelen F, Dora B, Balkan S. Orthostatic heart rate variability analysis in idiopathic Parkinson's disease. Acta Neurol Scand 2006; 113(5): 288-93.
22. Druschky A, Hilz MJ, Platsch G Radespiel-Tröger M, Druschky K, Kuwert T, et al. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-spect. J Neurol Sci. 2000; 175(1): 3-12.
23. Goldstein DS, Holmes C, Sewell L, Park MY, Sharabi Y. Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy. Clin Auton Res. 2011; 22(1): 57-61.
24. Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001; 57(3): 456-62.
25. Langston JW. The Parkinson's complex: parkinsonism is just the tip of the iceberg. Ann Neurol 2006; 59(4): 591-6.
26. Miyamoto T, Miyamoto M, Iwanami M, Hirata K. Cardiac 123IMIBG accumulation in Parkinson's disease differs in association with REM sleep behaviour disorder. Parkinsonism Relat Disord 2011; 17(3): 219-20.
27. Siddiqui MF, Rast S, Lynn MJ, Auchus AP, Pfeiffer RF. Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey. Parkinsonism Relat Disord 2002; 8(4): 277-84.
28. Riley DE, Chelimsky TC. Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease. J Neurol Neurosurg Psychiatry 2003; 74(1): 56-60.
29. Bouhaddi M, Vuillier F, Fortat JO, Capelle S, Henriet MT, Rumbach L, et al. Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy. Auton Neurosci 2004; 116(1-2): 30-8.
30. Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, van Hilten JJ. Patient-reported autonomic symptoms in Parkinson's disease. Neurology 2007; 69(4): 333-41.
31. Blackett H, Walker R, Wood B. Urinary dysfunction in Parkinson's disease: a review. Parkinsonism Relat Disord 2009; 15(2): 81-7.
32. Mathias C. Autonomic disorders and their recognition. N Engl J Med 1997; 336(10): 721-4.
33. Sakakibara R, Shinotoh H, Uchiyama T, Sakuma M, Kashiwado M, Yoshiyama M, et al. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease. Auton Neurosci 2001; 92(1-2): 76-85.
34. Lucetti C, Gambaccini G, Del Dotto P, Ceravolo R, Logi C, Rossi G, et al. Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement. Parkinsonism Relat Disord. 2006; 12(5): 279-83.